Benzyl cinnamate

CAS No. 103-41-3

Benzyl cinnamate( Cinnamein | ?Benzylcinnamoate | Benzyl 3-phenylpropenoate | Cinnamic acid benzyl ester )

Catalog No. M21171 CAS No. 103-41-3

Benzyl cinnamate is a natural product isolated from various plant specieswith anti-inflammatory activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 33 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 28 In Stock
1G 41 In Stock

Biological Information

  • Product Name
    Benzyl cinnamate
  • Note
    Research use only, not for human use.
  • Brief Description
    Benzyl cinnamate is a natural product isolated from various plant specieswith anti-inflammatory activity.
  • Description
    Benzyl cinnamate is a natural product isolated from various plant specieswith anti-inflammatory activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Cinnamein | ?Benzylcinnamoate | Benzyl 3-phenylpropenoate | Cinnamic acid benzyl ester
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Immunology & Inflammation related
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    103-41-3
  • Formula Weight
    238.28
  • Molecular Formula
    C16H14O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:47 mg/mL (197.24 mM)
  • SMILES
    O=C(/C=C/c1ccccc1)OCc1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bhatia SP et al. Fragrance material review on benzyl cinnamate. Food Chem Toxicol. 2007;45 Suppl 1:S40-8. Epub 2007 Sep 14.
molnova catalog
related products
  • Gnetifolin K

    Gnetifolin K (GnetifolinK) is a novel stilbene diglucoside from Gnetum parvifolium with potential neuroprotective activity for the study of DNA damage.

  • β- Amyloid (8-38)

    β- Amyloid (8-38)

  • AKOS037652256

    AKOS037652256 can be used as a TRPML modulator for the treatment of diseases associated with TRPML activity such as lysosomal accumulation disorders, muscular dystrophy, common age-related neurodegenerative diseases, oxidative stress or reactive oxygen species (ROS)-related diseases and ageing.